Insomnia Treatment Drugs Market Insights, Global Outlook and Forecast 2022-2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
The latest research study released by Market IntelliX evaluates market size and forecasts of Insomnia Treatment Drugs in Global, including the following market information:
Global Insomnia Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Insomnia Treatment Drugs market was valued at 3006.2 million in 2021 and is projected to reach US$ 3764 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Sleep Aids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Insomnia Treatment Drugs include F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd and Teva Pharmaceutical Industries Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Insomnia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Insomnia Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Insomnia Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Global Insomnia Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Insomnia Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Others
Global Insomnia Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Insomnia Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insomnia Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Insomnia Treatment Drugs revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Insomnia Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Treatment Drugs Overall Market Size
2.1 Global Insomnia Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Insomnia Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Treatment Drugs Players in Global Market
3.2 Top Global Insomnia Treatment Drugs Companies Ranked by Revenue
3.3 Global Insomnia Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Insomnia Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Insomnia Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Prescription Sleep Aids
4.1.3 Over the Counter (OTC) Sleep Aids
4.2 By Type - Global Insomnia Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Insomnia Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Insomnia Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Treatment Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Others
5.2 By Application - Global Insomnia Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Insomnia Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Insomnia Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Insomnia Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Insomnia Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Insomnia Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Insomnia Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Insomnia Treatment Drugs Revenue, 2017-2028
6.3.2 US Insomnia Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Insomnia Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Insomnia Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Insomnia Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Insomnia Treatment Drugs Market Size, 2017-2028
6.4.3 France Insomnia Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Insomnia Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Insomnia Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Insomnia Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Insomnia Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Insomnia Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Insomnia Treatment Drugs Revenue, 2017-2028
6.5.2 China Insomnia Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Insomnia Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Insomnia Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Insomnia Treatment Drugs Market Size, 2017-2028
6.5.6 India Insomnia Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Insomnia Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Insomnia Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Insomnia Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Insomnia Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Insomnia Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Insomnia Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Insomnia Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 F.Hoffman La-Roche AG
7.1.1 F.Hoffman La-Roche AG Corporate Summary
7.1.2 F.Hoffman La-Roche AG Business Overview
7.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Major Product Offerings
7.1.4 F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 F.Hoffman La-Roche AG Key News
7.2 Merck & Co. Inc.
7.2.1 Merck & Co. Inc. Corporate Summary
7.2.2 Merck & Co. Inc. Business Overview
7.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Major Product Offerings
7.2.4 Merck & Co. Inc. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Merck & Co. Inc. Key News
7.3 Mylan N.V.
7.3.1 Mylan N.V. Corporate Summary
7.3.2 Mylan N.V. Business Overview
7.3.3 Mylan N.V. Insomnia Treatment Drugs Major Product Offerings
7.3.4 Mylan N.V. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Mylan N.V. Key News
7.4 Pfizer, Inc.
7.4.1 Pfizer, Inc. Corporate Summary
7.4.2 Pfizer, Inc. Business Overview
7.4.3 Pfizer, Inc. Insomnia Treatment Drugs Major Product Offerings
7.4.4 Pfizer, Inc. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Pfizer, Inc. Key News
7.5 Pernix Therapeutics
7.5.1 Pernix Therapeutics Corporate Summary
7.5.2 Pernix Therapeutics Business Overview
7.5.3 Pernix Therapeutics Insomnia Treatment Drugs Major Product Offerings
7.5.4 Pernix Therapeutics Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 Pernix Therapeutics Key News
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Corporate Summary
7.6.2 Sanofi S.A. Business Overview
7.6.3 Sanofi S.A. Insomnia Treatment Drugs Major Product Offerings
7.6.4 Sanofi S.A. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 Sanofi S.A. Key News
7.7 Takeda Pharmaceutical Company Ltd.
7.7.1 Takeda Pharmaceutical Company Ltd. Corporate Summary
7.7.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Major Product Offerings
7.7.4 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 Takeda Pharmaceutical Company Ltd. Key News
7.8 Sumitomo Dainippon Pharma Co., Ltd
7.8.1 Sumitomo Dainippon Pharma Co., Ltd Corporate Summary
7.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
7.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Major Product Offerings
7.8.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.8.5 Sumitomo Dainippon Pharma Co., Ltd Key News
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News
7.10 Vanda Pharmaceuticals, Inc.
7.10.1 Vanda Pharmaceuticals, Inc. Corporate Summary
7.10.2 Vanda Pharmaceuticals, Inc. Business Overview
7.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Major Product Offerings
7.10.4 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.10.5 Vanda Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Insomnia Treatment Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|